Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

AIDS. 2003 Jul 4;17(10):1513-20. doi: 10.1097/00002030-200307040-00012.

Abstract

Objective: To examine baseline plasma viral loads according to the CD4 cell percentage (CD4%) in HIV-1, HIV-2 and dually infected patients (HIV-D), and to relate these measurements to survival.

Patients and methods: A total of 119 HIV-1, 137 HIV-2 and 81 HIV-D-infected patients attending the Medical Research Council clinic in The Gambia were recruited from 1991 according to baseline CD4%, and followed until death or the end of December 2000. HIV-1 and HIV-2 RNA levels were measured by in-house reverse transcriptase polymerase chain reaction assays.

Results: The plasma viral load, which varied inversely with CD4%, was similar in HIV-1 singly and dually infected patients, but was significantly higher in HIV-1 than in HIV-2 singly infected patients, except in those with a CD4% less than 14%. HIV-2 plasma viral load in dually infected patients did not vary significantly with CD4%, but was significantly lower than in HIV-2 singly infected patients with CD4% less than 14%. Multivariate analysis showed that only CD4% was independently associated with survival in HIV-1 and HIV-D infections; whereas both CD4% and plasma viral load were independently associated with survival in HIV-2 infections. The mortality rate of HIV-D-infected patients was not significantly different from that of HIV-1-infected patients, but was significantly higher in the absence of HLA B58.

Conclusion: HIV-2 infection does not alter HIV-1 replication or prolong survival in dually infected patients. In a clinical setting in Africa, where many patients present with advanced disease, CD4% may be a more important predictor of prognosis than plasma viral load.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / immunology*
  • Developing Countries*
  • Female
  • Follow-Up Studies
  • Gambia
  • HIV Infections / immunology*
  • HIV Infections / mortality
  • HIV Infections / virology*
  • HIV-1* / genetics
  • HIV-2* / genetics
  • HLA-B Antigens / analysis*
  • Humans
  • Immunophenotyping
  • Male
  • Middle Aged
  • RNA, Viral / analysis
  • Statistics as Topic
  • Survival Rate
  • Viral Load

Substances

  • HLA-B Antigens
  • RNA, Viral